|
Volumn 16, Issue 4, 2002, Pages 396-405
|
Does anti-angiogenic treatment make any contribution in cases of primary hepatocellular carcinoma? - With special reference to chemoprevention, tumor dormancy and tumor shrinkage
a
|
Author keywords
Angiogenesis; Anti angiogenic treatment; Endothelial cell proliferation inhibitor; Hepatocellular carcinoma; Matrix metalloproteinase inhibitor; Tissue remodeling
|
Indexed keywords
ANGIOGENESIS INHIBITOR;
FR 118487;
GAMMA INTERFERON;
GELATINASE A;
GELATINASE B;
INTERLEUKIN 8;
MARIMASTAT;
MATRILYSIN;
MATRIX METALLOPROTEINASE INHIBITOR;
STROMELYSIN;
UNCLASSIFIED DRUG;
ANGIOGENESIS;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANIMAL TISSUE;
ANTINEOPLASTIC ACTIVITY;
ARTIFICIAL EMBOLISM;
CANCER INFILTRATION;
CARCINOGENESIS;
CELL INFILTRATION;
CELL PROLIFERATION;
CHEMOPROPHYLAXIS;
CONFERENCE PAPER;
CONTROLLED STUDY;
DORMANCY;
FOLLOW UP;
IMMUNOHISTOLOGY;
LIVER CELL CARCINOMA;
NONHUMAN;
NORTHERN BLOTTING;
RAT;
ZYMOGRAPHY;
|
EID: 0036650227
PISSN: 09142223
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
Times cited : (2)
|
References (20)
|